Extensively Drug-Resistant TB Outcomes Remain Poor in Europe
Only four out of 10 patients with extensively drug-resistant tuberculosis in Europe achieved successful treatment outcomes, a rate markedly lower than that for other forms of drug-resistant tuberculosis and comparable with cure rates from the pre-antibiotic era.
METHODOLOGY:
Researchers conducted a retrospective observational cohort study across 16 countries of the World Health Organization (WHO) European Region to evaluate treatment outcomes in 188 patients (median age, 42 years; 79.3% men) with extensively drug-resistant tuberculosis.
Data collected included patient characteristics, disease localisation, prior treatments, phenotypic and genotypic drug susceptibility testing results, and treatment regimens.
Treatment outcomes were categorised as successful, failure (microbiological or clinical reasons including regimen changes), lost to follow-up (treatment interrupted for 2 or more months), or not evaluated.
TAKEAWAY:
Among the 188 patients with extensively drug-resistant tuberculosis, 48.4%, 34.0%, and 17.6% of Mycobacterium tuberculosis strains were resistant to bedaquiline alone, linezolid alone, and both drugs, respectively.
Among 156 patients with available data for treatment outcomes, 40.2% (95% CI, 28.4%-53.2%) achieved successful outcomes in a pooled analysis accounting for between-country heterogeneity.
Patients with extensively drug-resistant tuberculosis had lower pooled success rates (P < .0001) and significantly higher pooled rates of treatment failure and death (P < .0001 and P = .008, respectively) than those with multidrug-/rifampicin-resistant or preextensively drug-resistant tuberculosis.
The likelihood of an unsuccessful outcome decreased with each additional effective drug in the regimen (P = .026) but increased among patients treated in upper-middle-income countries compared with that among those treated in high-income countries (P < .001).
IN PRACTICE:
"[The study] findings underscore the need for improved, rapid DST [drug susceptibility testing] tools and effective, shorter treatment regimens for extensively drug-resistant tuberculosis," the authors wrote.
SOURCE:
This study was led by Yousra Kherabi, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France, and Ole Skouvig Pedersen, Aarhus University Hospital, Aarhus, Denmark. It was published online on July 15, 2025, in The Lancet Regional Health - Europe.
LIMITATIONS:
The coverage of the WHO European Region was limited. Most of the participating centres were specialist or referral centres, which may have introduced selection bias and limiting generalisability. Although the use of WHO-defined outcomes simplified data collection, it constrained a detailed understanding of treatment failures. Moreover, individual-level data were available only for patients with extensively drug-resistant tuberculosis, which may have introduced confounding from unmeasured patient-level factors.
DISCLOSURES:
This study did not receive any funding. One author reported serving as a co-principal investigator of clinical trials testing new regimens for multidrug-resistant tuberculosis, and some authors reported receiving honoraria for speaking engagements or serving on advisory boards of various pharmaceutical companies.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
11 minutes ago
- Gizmodo
Gluten Could Be Wrongly Blamed for Americans' Stomach Troubles
For many of us, gluten is a dietary villain, capable of causing all sorts of gastrointestinal troubles. Research out this week looks to complicate that narrative, however, finding that people are sometimes wrongly blaming gluten for triggering their symptoms of irritable bowel syndrome. Scientists at McMaster University in Canada conducted the study, a small, randomized trial of IBS patients. People became sicker just as often after eating food containing gluten or wheat as they did after eating food without the ingredient, they found. Gluten is likely safer to eat for those with IBS than commonly thought, the researchers say. 'These findings suggest that expectations played a major role in symptom generation and that only some of these patients could benefit from gluten or wheat restriction,' they wrote in their paper, published Monday in The Lancet Gastroenetrology and Hepatology. IBS is a complex, chronic, and relatively common condition, estimated to affect between 5 and 10% of the population worldwide (including up to 45 million people in the U.S.). Its symptoms include stomach pain, bloating, and diarrhea or constipation. Unlike the closely named inflammatory bowel disorder, IBS isn't marked by physical changes or visible damage along the digestive tract, but it can still be a debilitating burden for many, with around 20% of sufferers experiencing severe bouts. The exact causes of IBS remain unclear, though scientists have speculated it can arise from a miscommunication between the nerves found in the gut and the brain. People with IBS tend to report having specific triggers that can cause a flare-up of illness, gluten included, and often manage their condition by avoiding these triggers. The researchers behind the new study aimed to better understand gluten's potential role in IBS, so they recruited over two dozen people with IBS for their randomized, double-blinded trial, all of whom had reported improving after switching to a gluten-free diet. At first, the volunteers were randomly assigned to one of three groups. All the groups were first told to eat cereal bars for a week. One group ate bars made with flour containing gluten, the second ate bars made with wheat flour, and the third ate bars made with gluten- and wheat-free flour. Afterward, the volunteers took a break for two weeks. Then they switched to eating the bars they hadn't eaten yet for another round of testing, a process repeated twice. By the study's end, all the volunteers had eaten all three kinds of bars, though on different schedules and without knowing which bars they had eaten on a given week. A total of 28 people completed the trial. A significant percentage of people reported having worsening IBS symptoms after eating gluten or wheat bars, the study showed, but about just as often as they did after eating non-gluten/wheat bars (roughly a third experienced worsening IBS during each of the three conditions). 93% of participants also reported having adverse events after each scenario of bar-eating. Interestingly enough, tests of the participants' stool found that only a third strictly followed their diets as instructed, with likely many fearing they would get sick. The findings are based on a very small sample size, so it's not yet certain that they apply to the general population of people with IBS tied to gluten. There are also, of course, digestive conditions clearly caused by an intolerance to gluten, particularly celiac disease. And the researchers aren't saying gluten can't sometimes be a genuine trigger for people's IBS. But they argue that in many cases, people's negative perception of gluten is causing a nocebo effect, the dark cousin of the placebo effect. In other words, someone's belief that gluten is bad for them can potentially spark or worsen the IBS symptoms seen after eating it, rather than gluten itself. The researchers say better communication and follow-up care from doctors are needed for IBS patients, given the findings. 'What we need to improve in our clinical management of these patients is to work with them further, not just tell them that gluten is not the trigger and move on. Many of them may benefit from psychological support and guidance to help destigmatize gluten and wheat and reintroduce them safely in their diet,' said senior author Premysl Bercik, a professor at McMaster's Department of Medicine, in a statement from the university. That may be easier said than done, though. The researchers note that most patients, upon learning the team's findings, staunchly refused to entertain the idea of gluten not being a trigger for their IBS symptoms. So it looks like gluten may need a promotional campaign to win back its reputation.
Fox News
42 minutes ago
- Fox News
Overdosing tourists in vacation hotspot are straining local health system
The popular Spanish island of Ibiza has had a longstanding reputation as a party hotspot for tourists — but those partying too hard are straining local health resources. A quarter of the ambulance emergencies are linked to large leisure centers, Spanish publication reported. The Works Council of the Union of Healthcare Technicians (WCUHT) told the outlet most of the calls are due to drugs or alcohol incidents at clubs involving foreign tourists — leaving ambulance technicians strained. "The situation is entrenched because the population increases, leisure centers increase, and instead of moving forward we go backward," said union president José Manuel Maroto. In 2024, about 3.28 million people visited Ibiza, while there were 3.38 visitors the year prior, according to the Ibiza Preservation. "Serving tourists from nightclubs saturates the service and harms other emergencies on the island, which have to endure delays in ambulances," said Maroto. A European Psychiatry study published by Cambridge University Press analyzed drug-related fatalities in Ibiza from 2010 to 2016. The study found that MDMA and cocaine were the most commonly used substances, with the number of fatalities per year "steadily increasing." Party promoter Wayne Anthony told Sky News last year he does not think the drug problem in Ibiza will be stopped. "When you have these movements that are driven by music, that are driven by art, that are driven by fashion and drugs are a part of it, whatever you put up, whatever boundaries, whatever laws, I don't think you're going to be able to stop it," said Wayne. He arrived on the island in 1988, noting that "what Ibiza represented was this beautiful, hot island, which was visually stunning and we knew you could party there quite legally." The Center for Public Health researchers at Liverpool John Moores University published a 2014 study on the behavior of young British tourists between the ages of 16 and 35. Of those surveyed, 85.3% reported using illicit drugs — while 54.1% smoked tobacco. The WCUHT is calling for clubs to work with their own private ambulance services. "Clubs are obliged to have a health service with nurses and even emergency technicians, but they are not forced to hire an ambulance service, and this ends up becoming a public system," said Maroto. He added, "We all pay for ambulances to these companies that make billions. It is unaffordable."
Forbes
42 minutes ago
- Forbes
International Resistance To AI In Education Marked In Open Letter
Breaking the techno-ties that bind As the use spreads of computer tools marketed as artificial intelligence, some educators and even entire institutions are embracing the new tech. For example, Ohio State University has anounced a bold AI Fluency initiative to redefine learning and innovation. But some educators are pushing back against the 'inevitable' technology, and open letters are becoming one tool of the resistance. Literary Hub published a letter from authors addressed to publishers. In the Netherlands, over 900 educators have signed a letter entitled 'Stop the Uncritical Adoption of AI Technologies in Academia.' The unfettered introduction of AI technology leads to contravention of the spirit of the EU Al act. It undermines our basic pedagogical values and the principles of scientific integrity. It prevents us from maintaining our standards of independence and transparency. And most concerning, AI use has been shown to hinder learning and deskill critical thought. Earlier in July, another open letter launched 'from educators who refuse the call to adopt GenAI in education.' Melanie Dusseau (University of Findlay) and Miriam Reynoldson (RMIT University) got the petition up and running, and to date over 700 educators have signed on in just two weeks. Dusseau has previously spoken out about AI in education with an article at Inside Higher Ed last November, arguing that resistance is not futile. If you are tired of the drumbeat of inevitability that insists English faculty adopt AI into our teaching practices, I am here to tell you that you are allowed to object. Using an understanding of human writing as a means to allow for-profit technology companies to dismantle the imaginative practice of human writing is abhorrent and unethical. Writing faculty have both the agency and the academic freedom to examine generative AI's dishonest training origins and conclude: There is no path to ethically teach AI skills. The open letter declares that 'Current GenAI technologies represent unacceptable legal, ethical and environmental harms,' that it is 'a threat to student learning and wellbeing,' and that it is "overwhelmingly aimed at automating and replacing human effort.' The open letter includes a series of pledges, including a refusal to use AI to design or evaluate coursework, nor include 'AI literacy' in course design. They also pledge to resist marketing hype, especially that coming from salespeople who are net themselves educators (a problem in education that predates the invention of the computer). Numerous writers tout the 'inevitability' of AI in education {the London School of Science and Technology published a whole post about 'the futility of resisting AI in education'). But there are also voices arguing against any rush to AI adoption. Scott Latham, Ph.D., a professor of strategy at the Manning School of Business at the University of Massachusetts, wrote a 'memo to teachers' at Inside Higher Ed last year, 'AI Is Not Your Friend' And writing educator John Warner mounts a defense of humanity in writing and writing instruction is his new book, More Than Words. Dusseau said via email that she and Reynoldson 'wanted to do something that focused on autonomy and academic freedom in the face of the many ethical concerns surrounding generative AI technology.' What they created was one more sign of international resistance to GenAI.
